Gland Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

4,167.43

3,616.53

4,400.71

3,462.88

2,633.24

Operating profit

1,408.78

1,018.55

1,510.64

1,302.27

955.47

Interest

7.84

7.41

5.24

3.41

7.18

Gross profit

1,567.60

1,251.60

1,729.34

1,433.63

1,087.45

EPS (Rs)

63.34

47.11

73.78

60.95

49.88

Other income

166.67

240.46

223.94

134.78

139.17

Stock adjustment

87.43

-46.92

36.69

-273.49

-6.90

Raw material

1,709.74

1,716.75

2,046.86

1,749.16

1,090.25

Power and fuel

117.20

124.84

95.05

74.59

-

Employee expenses

409.95

399.70

338.57

311.36

277.66

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

434.34

403.61

372.90

298.99

316.76

Provisions made

-

-

-

-

-

Depreciation

162.11

146.74

110.30

98.78

94.59

Taxation

362.17

272.58

406.89

337.85

220.01

Net profit / loss

1,043.33

775.83

1,212.16

997.01

772.86

Extra ordinary item

-

-56.46

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.47

16.47

16.43

16.36

15.50

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

33.80

28.16

34.33

37.61

36.28

GPM (%)

36.17

32.45

37.39

39.85

39.22

NPM (%)

24.07

20.11

26.21

27.71

27.88